THE SENATE

THE TWENTY-FOURTH LEGISLATURE

REGULAR SESSION OF 2008

 

COMMITTEE ON HEALTH

Senator David Y. Ige, Chair

Senator Carol Fukunaga, Vice Chair

 

 

MEASURES DEFERRED TO THURSDAY, FEBRUARY 14, 2008

 

DATE:

Thursday, February 14, 2008

TIME:

9:30 a.m.

PLACE:

Conference Room 211

State Capitol

415 South Beretania Street

 

DECISION MAKING ON THE FOLLOWING MEASURE(S):

(Deferred from Wednesday, February 13, 2008)

 

SB 3136

Testimony

MAKING AN APPROPRIATION TO THE DEPARTMENT OF HEALTH FOR A MONUMENT TO BE PLACED IN KALAWAO COUNTY RECOGNIZING THOSE WHO WERE SENT TO KALAUPAPA WITH HANSEN'S DISEASE.

Makes an appropriation to the department of health for a monument to be placed in Kalawao county recognizing those who were sent to Kalaupapa with Hansen's disease.

 

HTH, WAM

SB 2851

Testimony

RELATING TO HEALTH.

Amends the informed written consent and pre-test counseling requirements to provide for voluntary HIV testing as a routine part of clinical care.  Makes an appropriation.

 

HTH, WAM

SB 2890

Testimony

MAKING AN APPROPRIATION FOR HEALTH CARE SERVICES.

Appropriates funds to the department of health for health care and related services to people living with the human immunodeficiency virus or acquired immunodeficiency syndrome.

 

HTH, WAM

SB 2703

Testimony

RELATING TO THE HOSPITAL LOAN GUARANTEE PROGRAM.

Establishes a hospital loan guarantee program to guarantee a portion of a loan by a private financial institution to a hospital that is experiencing short-term financial problems.  Repealed 6/30/20  .

 

HTH, WAM

SB 2704

Testimony

RELATING TO HOSPITALS.

Establishes a hospital capital loan program under department of health.  Requires loan to Hawaii Medical Center, LLC.

 

HTH, WAM

SB 3015

Testimony

RELATING TO THE PATIENTS' BILL OF RIGHTS AND RESPONSIBILITIES ACT.

Amends the Patients' Bill of Rights and Responsibilities Act by prohibiting certain unfair or deceptive business practices by managed care plans, such as disenrolling a person because of a medical condition.

 

HTH, CPH

SB 3078

Testimony

RELATING TO WORKSITE WELLNESS PROGRAMS.

Gives State and counties immunity from liability for injury and damage that occur as a result of voluntary participation in state and county worksite wellness programs.

 

HTH, JDL

SB 2063

Testimony

RELATING TO NOISE.

Increases the fine for exhaust pipes or mufflers that increase the noise emitted by a moped, motorcycle, or motor vehicle.

 

HTH, JDL

SB 2770

Testimony

RELATING TO MOTOR VEHICLE INSURANCE.

Exempts motor vehicle insurers from being required to make available to the insured, at the insured's option, personal injury protection benefits through managed care, if there are fewer than 5 managed care providers or equivalent entities within 25 miles of the claimant.

 

HTH, CPH

SB 3017

Testimony

RELATING TO INSURANCE.

Improves the Insurance Commissioner's ability to protect consumers from improper transactions between health insurance companies and their affiliates by authorizing the Commissioner to monitor the relationships and transactions between these companies and their affiliates.

 

HTH, CPH

SB 3012

Testimony

RELATING TO MOTOR VEHICLE INSURANCE.

In determining motor vehicle insurance policy personal injury protection benefits, imposes the same limitations on the number of visits, charge per visit, and combined total visits for therapeutic massage treatments as are imposed on naturopathic, chiropractic, and acupuncture treatments.

 

HTH, CPH

SB 2412

Testimony

RELATING TO MEDICAL LIABILITY.

Limits noneconomic damages that may be recovered in medical tort actions.  Limits the amount of attorney's fees that may be collected in connection with a medical tort action.

 

HTH, JDL

SB 2354

Testimony

RELATING TO MEDICAL LIABILITY.

Limits noneconomic damages that may be recovered in medical tort actions.  Limits the amount of attorney's fees that may be collected in connection with a medical tort action.  Amends the definition of "health care provider" and "medical tort".  Sunsets on the earlier of the date on which an insurer does not comply with the premium rate caps, or July 1, 2015.

 

HTH, JDL

SB 2413

Testimony

RELATING TO INSURANCE.

Repeals the health insurance rate filing requirements in order to charge health care insurance companies the responsibility of determining their own rates.

 

HTH, CPH

SB 2859

Testimony

RELATING TO TOBACCO PRODUCTS.

Prohibits use of tobacco products by minors.  Requires minor to complete a tobacco use cessation program, perform community service, and have his or her driver's license revoked for one year.

 

HTH, JDL

SB 2460

Testimony

RELATING TO CONTROLLED SUBSTANCES.

Prohibits pre-signed and predated prescriptions.  Clarifies how the narcotic enforcement division administrator shall conduct inspections at pharmacies.

 

HTH, JDL

SB 2536

Testimony

RELATING TO THE I-SAVERX PRESCRIPTION DRUG PROGRAM.

Directs governor to establish the State of Hawaii's participation in the I-SaveRx prescription drug program to provide residents with increased access to affordable drugs.

 

HTH, CPH

SB 2491

Testimony

RELATING TO HEALTH.

Establishes a health and safety program within the department of health and an oversight committee for biological research laboratories and facilities that study and contain biological agents, human pathogens, or toxins in Hawaii.

 

HTH, WAM

SB 2789

Testimony

RELATING TO LIABILITY.

Exempts from liability emergency care rendered by a health care provider or health care facility in response to specified emergencies.

 

HTH, JDL

SB 2492

Testimony

RELATING TO HOSPITAL-ACQUIRED INFECTIONS.

Enacts the hospital-acquired infection disclosure and hospital-acquired infection prevention law to detect, report, and prevent organism caused infections in hospitals and medical facilities.

 

HTH, WAM

SB 2131

Testimony

RELATING TO HEALTH.

Requires health insurance providers to cover treatments for cancer.

 

HTH, CPH

SB 2533

Testimony

RELATING TO ADVERTISING BY MANUFACTURERS OF PRESCRIPTION DRUGS AND DISCLOSURE OF CLINICAL TRIALS.

Requires prescription drug ads to meet federal standards, public disclosure of clinical trial information, and drug manufacturers to pay fees to department of health to fund a public education initiative on clinical trials and drug safety.  Establishes special fund.

 

HTH, WAM

SB 3016

Testimony

RELATING TO MUTUAL BENEFIT SOCIETIES.

Maintains competition and consumer choice by deleting requirements that pose obstacles to smaller health plans.  Deletes requirement that health plans must maintain a fund equal to "one half of twenty times the maximum benefits paid in 30 days" and caps the deposit requirement at $20 million.

 

HTH, CPH

SB 2928

Testimony

RELATING TO THE RIGHT OF CONSCIENCE.

Establishes a right of conscience for healthcare providers, institutions, and payers who do not want to participate, provide, or pay for medical services that violate their conscience, including abortions, artificial birth control, artificial insemination, assisted reproduction, human cloning, euthanasia, human embryonic stem cell research, fetal experimentation, physician assisted suicide, and sterilization.

 

HTH, JDL

SB 2314

Testimony

RELATING TO INSURANCE.

Allows an exception for small insurers with less than ten per cent of the market share to offer different types of benefits in a single unified policy.

 

HTH, CPH

 

 

 

 

 

No testimony will be accepted.

 

FOR FURTHER INFORMATION, PLEASE CALL THE COMMITTEE CLERK AT 808-586-6230.